Differential effects of antiepileptic drugs on human bone cells

被引:15
|
作者
Rocha, Sara [1 ,2 ,3 ]
Ferraz, Ricardo [2 ,3 ,4 ]
Prudencio, Cristina [2 ,3 ,5 ]
Fernandes, Maria Helena [1 ,4 ]
Costa-Rodrigues, Joao [1 ,5 ,6 ,7 ]
机构
[1] Univ Porto, Fac Dent Med, Lab Bone Metab & Regenerat, Porto, Portugal
[2] Inst Politecn Porto, Escola Super Saude, CQB, Porto, Portugal
[3] Inst Politecn Porto, Escola Super Saude, CISA, Porto, Portugal
[4] Univ Porto, REQUIMTE LAQV, Porto, Portugal
[5] Univ Porto, i3S, Inst Inovacao & Invest Saude, Porto, Portugal
[6] ESS, Porto, Portugal
[7] Escola Super Saude, Inst Politecn Viana Castelo, Porto, Portugal
关键词
antiepileptic drugs; osteoblastogenesis; osteoclastogenesis; LONG-TERM VALPROATE; MINERAL DENSITY; PLASMA-CONCENTRATION; PEDIATRIC-PATIENTS; METABOLISM; CHILDREN; ACID; CARBAMAZEPINE; TOPIRAMATE; TURNOVER;
D O I
10.1002/jcp.28569
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Antiepileptic drugs (AED) have been associated to in vivo deleterious consequences in bone tissue. The present work aimed to characterize the cellular and molecular effects of five different AED on human osteoclastogenesis and osteblastogenesis. It was observed that the different drugs had the ability to differentially modulate both processes, in a way dependent on the identity and dose of the AED. Shortly, valproic acid stimulated either osteoclastogenesis and osteoblastogenesis, whereas carbamazepine, gabapentin, and lamotrigine revealed an opposite behavior; topiramate elicited a decrease of osteoclast development and an increase in osteoblast differentiation. This is the first report describing the direct effects of different AED on human primary bone cells, which is a very important issue, because these drugs are usually consumed in long-term therapeutics, with acknowledged in vivo effects in bone tissue.
引用
收藏
页码:19691 / 19701
页数:11
相关论文
共 50 条
  • [1] Differential cognitive effects of antiepileptic drugs
    Bourgeois, BFD
    JOURNAL OF CHILD NEUROLOGY, 2002, 17 : 2S28 - 2S33
  • [2] Antiepileptic drugs and their effects on bone metabolism
    Bozdemir, H
    Koc, F
    Yerdelen, D
    Aslan, K
    EPILEPSIA, 2004, 45 : 160 - 160
  • [3] Differential effects of antiepileptic drugs on steroidogenesis in a human in vitro cell model
    Gustavsen, M. W.
    von Krogh, K.
    Tauboll, E.
    Zimmer, K. E.
    Dahl, E.
    Olsaker, I.
    Ropstad, E.
    Verhaegen, S.
    ACTA NEUROLOGICA SCANDINAVICA, 2009, 120 : 14 - 21
  • [4] Differential effects of antiepileptic drugs on neonatal outcomes
    Pennell, P. B.
    Klein, A. M.
    Browning, N.
    Baker, G. A.
    Clayton-Smith, J.
    Kalayjian, L. A.
    Liporace, J. D.
    Privitera, M.
    Crawford, T.
    Loring, D. W.
    Meador, K. J.
    EPILEPSY & BEHAVIOR, 2012, 24 (04) : 449 - 456
  • [5] The evaluation of the effects of antiepileptic drugs on bone metabolism
    Giray, Tuba
    Vitrinel, Ayca
    Comert, Serdar
    Deniz, NeslihanCicek
    Erdag, Gulay Ciler
    Kesler, Esma
    Sadikoglu, Semiramis
    Akin, Yasemin
    TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS, 2005, 40 (03): : 221 - 226
  • [6] Differential and dose dependent effects of in utero Antiepileptic drugs
    Meador, KJ
    Loring, DW
    Baker, G
    Smith, JC
    Pennell, P
    Liporace, J
    Kalayjian, L
    Kini, U
    NEUROLOGY, 2005, 64 (06) : A427 - A427
  • [7] Adverse effects of antiepileptic drugs on bone mineral density
    Babayigit, Arzu
    Dirik, Eray
    Bober, Ece
    Cakmakci, Handan
    PEDIATRIC NEUROLOGY, 2006, 35 (03) : 177 - 181
  • [8] The effects of antiepileptic drugs on bone health: A systematic review
    Griepp, Daniel W.
    Kim, David J.
    Ganz, Marc
    Dolphin, Eugene J.
    Sotudeh, Nadia
    Burekhovich, Steven A.
    Naziri, Qais
    EPILEPSY RESEARCH, 2021, 173
  • [9] Antiepileptic drugs and bone disease
    Pack A.M.
    Clinical Reviews in Bone and Mineral Metabolism, 2004, 2 (2): : 159 - 165
  • [10] Antiepileptic drugs and bone metabolism
    Valsamis, Helen A.
    Arora, Surender K.
    Labban, Barbara
    McFarlane, Samy I.
    NUTRITION & METABOLISM, 2006, 3 (1)